Please login to the form below

Not currently logged in
Email:
Password:

glycopyrronium

This page shows the latest glycopyrronium news and features for those working in and with pharma, biotech and healthcare.

Novartis reveals full phase 3 results for Enerzair Breezhaler

Novartis reveals full phase 3 results for Enerzair Breezhaler

The results, which were published in The Lancet Respiratory Medicine, found that the Enerzair Breezhaler (indacaterol acetate, glycopyrronium bromide and mometasone furoate, IND/GLY/MF) demonstrated statistically significant improvements in lung

Latest news

More from news
Approximately 2 fully matching, plus 41 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...